Linezolid is best used for :
**Core Concept:** Linezolid is a synthetic antibiotic in the oxazolidinone class, used to treat certain bacterial infections. It works by inhibiting bacterial protein synthesis, specifically by binding to the 50S ribosomal subunit and preventing the formation of 23S rRNA-tRNA interactions, thereby preventing bacterial growth and multiplication.
**Why the Correct Answer is Right:** Linezolid is primarily effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Its narrow spectrum of activity allows for a reduced risk of selecting resistant bacterial strains and drug interactions.
**Why Each Wrong Option is Incorrect:**
A. Linezolid is not primarily effective against Gram-negative bacteria, which makes option A incorrect. Gram-negative bacteria usually have an outer membrane that makes them more resistant to antibiotics.
B. Linezolid's mechanism of action does not target viruses or fungi, making option B incorrect. Its activity is limited to bacterial infections.
C. Linezolid's activity is not restricted to infections caused by anaerobic bacteria only. While it can be used in certain anaerobic infections, option C is not an exhaustive description of its clinical usage.
D. Linezolid is not primarily used for treating tuberculosis, which makes option D incorrect. It is mainly used for Gram-positive bacterial infections.
**Clinical Pearl:** Linezolid should not be used in patients with a history of peripheral neuropathy or optic neuritis as it may cause these side effects due to its inhibition of central and peripheral myelinated neurons. This highlights the importance of considering patient-specific factors while prescribing antibiotics.
**Correct Answer:** C. Linezolid is primarily used for treating infections caused by Gram-positive bacteria, including MRSA and VRE. However, this answer is not comprehensive, as linezolid can also be used for other infections like anaerobic infections and some cases of community-acquired pneumonia.